Literature DB >> 11375770

Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.

A Tropsha1, W Zheng.   

Abstract

The pharmacophore concept is central to the rational drug design and discovery process. Traditionally, a pharmacophore is defined as a specific three-dimensional (3D) arrangement of chemical functional groups found in active molecules, which are characteristic of a certain pharmacological class of compounds. Herein, by analogy with 3D pharmacophores, a more general concept of descriptor pharmacophore is introduced. The descriptor pharmacophores are defined by the means of variable selection QSAR as a subset of molecular descriptors that afford the most statistically significant structure-activity correlation. The two variable selection QSAR methods developed in this laboratory are discussed; these include Genetic Algorithms--Partial Least Squares (GA-PLS) and K-Nearest Neighbors (KNN). Both methods employ multiple topological descriptors of chemical structures such as molecular connectivity indices or atom pairs (AP), and stochastic optimization algorithms to achieve a robust QSAR model, which is characterized by the highest value of cross-validated R2 (q2). By default, the descriptor pharmacophore represents an invariant selection of descriptor types however, descriptor values are generally different for different molecules. We demonstrate that chemical similarity searches using descriptor pharmacophores as opposed to using all descriptors afford more efficient mining of chemical databases or virtual libraries to discover compounds with a desired biological activity.

Mesh:

Substances:

Year:  2001        PMID: 11375770     DOI: 10.2174/1381612013397834

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

Authors:  Eva K Freyhult; Karl Andersson; Mats G Gustafsson
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

2.  Rational selection of training and test sets for the development of validated QSAR models.

Authors:  Alexander Golbraikh; Min Shen; Zhiyan Xiao; Yun-De Xiao; Kuo-Hsiung Lee; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

3.  Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.

Authors:  Jose Luis Medina-Franco; Alexander Golbraikh; Scott Oloff; Rafael Castillo; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2005-04       Impact factor: 3.686

4.  Discovery of Natural Product-Derived 5-HT1A Receptor Binders by Cheminfomatics Modeling of Known Binders, High Throughput Screening and Experimental Validation.

Authors:  Man Luo; Terry-Elinor Reid; Xiang Simon Wang
Journal:  Comb Chem High Throughput Screen       Date:  2015       Impact factor: 1.339

5.  Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human A3 adenosine receptor ligands.

Authors:  Liane Saíz-Urra; Marta Teijeira; Virginia Rivero-Buceta; Aliuska Morales Helguera; Maria Celeiro; Ma Carmen Terán; Pedro Besada; Fernanda Borges
Journal:  Mol Divers       Date:  2015-07-24       Impact factor: 2.943

6.  Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation.

Authors:  Yuri K Peterson; Xiang S Wang; Patrick J Casey; Alexander Tropsha
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

Review 7.  Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor.

Authors:  Chia-Hsien Lee; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Int J Mol Sci       Date:  2011-08-17       Impact factor: 5.923

8.  Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands.

Authors:  Man Luo; Xiang Simon Wang; Bryan L Roth; Alexander Golbraikh; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2014-02-12       Impact factor: 4.956

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.